C. Hernández-García

发表

Costs and predictors of costs in rheumatoid arthritis: a prevalence-based study.

Emilio Vargas, Pablo Lázaro, L. Abasolo, 2003, Arthritis and rheumatism.

Early T-cell activation in elderly humans.

J. Jover, B. Fernández-Gutiérrez, J. Ribera, 1996, Age and ageing.

Increased risk of tuberculosis in patients with rheumatoid arthritis.

L. Carmona, I. González-Álvaro, M. Belmonte, 2003, The Journal of rheumatology.

Undiagnosed spondyloarthropathy in patients presenting with anterior uveitis.

J. Jover, B. Fernández-Gutiérrez, E. Pato, 2000, The Journal of rheumatology.

Eye involvement in the spondyloarthropathies.

J. Jover, B. Fernández-Gutiérrez, C. Hernández-García, 1998, Rheumatic diseases clinics of North America.

Methotrexate treatment in the management of giant cell arteritis.

J. Jover, B. Fernández-Gutiérrez, C. Hernández-García, 1994, Scandinavian journal of rheumatology.

Management of rheumatoid arthritis in Spain (emAR II). Clinical characteristics of the patients.

L. Carmona, M. J. García de Yébenes, C. Hernández-García, 2012, Reumatologia clinica.

Functional integrity of the CD28 co-stimulatory pathway in T lymphocytes from elderly subjects.

J. Jover, B. Fernández-Gutiérrez, J. Ribera, 1999, Age and ageing.

Defective early T and T-dependent B cell activation in systemic lupus erythematosus

J. Jover, B. Fernández-Gutiérrez, C. Hernández-García, 1998, Lupus.

[Justification to health managers: cost-benefit of osteoporosis management].

C. Hernández-García, 2011, Reumatologia clinica.

Differences between rheumatology attending physicians and training residents in the management of rheumatoid arthritis in Spain

L. Abasolo, J. Jover, B. Fernández-Gutiérrez, 2008, Scandinavian journal of rheumatology.

Treatment of refractory posterior uveitis with infliximab: a 7‐year follow‐up study

E. Pato, E. Loza, C. Hernández-García, 2009, Scandinavian journal of rheumatology.

The CD69 activation pathway in rheumatoid arthritis synovial fluid T cells.

J. Jover, B. Fernández-Gutiérrez, C. Hernández-García, 1996, Arthritis and rheumatism.

Human parvovirus B19, varicella zoster virus, and human herpesvirus-6 in mesenchymal stem cells of patients with osteoarthritis: analysis with quantitative real-time polymerase chain reaction.

J. Jover, B. Fernández-Gutiérrez, L. López-Durán, 2007, Osteoarthritis and cartilage.

Patterns of uveitis as a guide in making rheumatologic and immunologic diagnoses.

J. Jover, B. Fernández-Gutiérrez, J. Castillo, 1997, Arthritis and rheumatism.

Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.

P. Merkel, J. Jover, B. Fernández-Gutiérrez, 2007, Arthritis and rheumatism.

Regeneración de maíces blancos subtropicales vía embriogénesis somática

C. Hernández-García, E. Cárdenas-Soriano, A. Pellegrineschi, 2007 .

Characterization and regulation of CD69 expression on rheumatoid arthritis synovial fluid T cells.

J. Jover, B. Fernández-Gutiérrez, C. Hernández-García, 1995, The Journal of rheumatology.

Bowel inflammation in anterior uveitis and spondyloarthropathy.

J. Jover, B. Fernández-Gutiérrez, C. Hernández-García, 1995, The Journal of rheumatology.

The prevalence of rheumatoid arthritis in the general population of Spain.

L. Carmona, R. Gabriel, L Carmona, 2002, Rheumatology.

Musculoskeletal work disability for clinicians: time course and effectiveness of a specialized intervention program by diagnosis.

L. Abasolo, L. Carmona, J. Jover, 2007, Arthritis and rheumatism.

Disparate results in studies of methotrexate plus corticosteroids in the treatment of giant cell arteritis: comment on the article by Hoffman et al.

J. Jover, B. Fernández-Gutiérrez, C. Hernández-García, 2003, Arthritis and rheumatism.

Prognostic factors in short-term disability due to musculoskeletal disorders.

L. Abasolo, L. Carmona, J. Jover, 2008, Arthritis and rheumatism.

Variability in Resource Consumption in Patients With Spondyloarthritis in Spain. Preliminary Descriptive Data From the emAR II Study

L. Carmona, E. Loza, C. Hernández-García, 2012 .

[Reduction in time until first treatment with disease modifying treatment in patients with rheumatoid arthritis].

L. Abasolo, B. Fernández-Gutiérrez, C. Vadillo, 2007, Reumatologia clinica.

Variability in the use of orthopedic surgery in patients with rheumatoid arthritis in Spain.

L. Abasolo, J. Jover, B. Fernández-Gutiérrez, 2007, The Journal of rheumatology.

Orthopedic Surgery in Rheumatoid Arthritis in the Era of Biologic Therapy

L. León, L. Abasolo, L. Rodríguez-Rodríguez, 2013, The Journal of Rheumatology.

Variability in resource consumption in patients with spondyloarthritis in Spain. Preliminary descriptive data from the emAR II study.

L. Carmona, E. Loza, M. J. García de Yébenes, 2012, Reumatologia clinica.

[Variations in the drug treatment of rheumatoid arthritis in Spain].

I. González-Álvaro, C. Hernández-García, E. Vargas, 2002, Medicina clinica.

Direct medical costs and their predictors in the EMAR-II cohort: "Variability in the management of rheumatoid arthritis and spondyloarthritis in Spain".

L. León, L. Abasolo, J. Jover, 2017, Reumatologia clinica.

Direct Medical Costs and Its Predictors in EMAR-II Cohort

L. León, L. Abasolo, J. Jover, 2017 .

Lag time between onset of symptoms and access to rheumatology care and DMARD therapy in a cohort of patients with rheumatoid arthritis.

J. Jover, B. Fernández-Gutiérrez, E. Pato, 2000, The Journal of rheumatology.

Treatment of refractory posterior uveitis with infliximab: a 7‐year follow‐up study

E. Pato, C. Hernández-García, R. Méndez, 2009, Scandinavian journal of rheumatology.